TradingView
DEXWireNews
2020年6月23日上午9點42分

$AFMD Affimed Upside Targets  看多

NASDAQ:AFMD1D
Affimed N.V.NASDAQ

描述

⋅
Affimed NV engages in discovering and developing of targeted cancer immunotherapies. Its pipelines include Innate Cell Engagers and T Cell Engagers. The company was founded in 2000 and is headquartered in Heidelberg, Germany.
Trend AnalysisHarmonic PatternsChart Patterns
更多